Animal Aids Market By Product Type (Medicinal Products, Nutritional Supplements, Diagnostic Products, Surgical Equipment, Wound Care Products) , By Animal Type (Companion Animals, Livestock Animal, Wildlife Animal.) By End User (Veterinary Clinics and Hos

Animal Aids Market By Product Type (Medicinal Products, Nutritional Supplements, Diagnostic Products, Surgical Equipment, Wound Care Products) , By Animal Type (Companion Animals, Livestock Animal, Wildlife Animal.) By End User (Veterinary Clinics and Hospitals, Animal Shelters and Rescue Center, Farms and Ranches, Pet Owners) : Global Opportunity Analysis and Industry Forecast, 2024-2033


The animal aids market was valued at $0.9 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.
Animal aids are tools, devices, and services designed for the well-being of animals. These can range from medical aids like prosthetics and wheelchairs to behavioral aids such as training tools and enrichment toys. Veterinary services and therapeutic treatments are also covered under animal aids, which ensure that animals receive the care and support, thus promoting animal welfare.
The growth of the global animal aids market is driven by rise in pet ownership and increase in public awareness and concern for the well-being of animals. According to the 2024 statistics determined by Forbes Advisor—a U.S.-based business magazine—approximately 86.9 million homes in the U.S. own a pet. With increasing adoption of pets, the demand for animal care products and services is expected to rise simultaneously, thereby fostering the growth of the animal aids market. Furthermore, increase in lifespan of pets and surge in disposable income encourage pet owners to spend more on their pets' health and well-being, thus boosting the sale of medical and supportive aids. Moreover, increase in penetration of wearable technology and smart feeding systems notably contributes toward the growth of the market. For instance, devices such as GPS trackers and health monitors are being used to track the daily activities for pets. In addition, pet owners are increasingly turning to automated feeders and water dispensers that can be controlled via smartphone apps, providing convenience and ensuring their pets are fed and hydrated on schedule even when they are not home. However, high costs associated with advanced animal aids and veterinary treatments and dearth of veterinary professionals trained in using and prescribing advanced animal aids significantly restrain the growth of the market. On the contrary, supportive government policies promoting animal health and welfare are expected to offer lucrative opportunities for the expansion of the global market during the forecast period. For instance, the World Organisation for Animal Health (WOAH) aims to improve global animal health and welfare by enhancing the capacity of veterinary services. Furthermore, increase in penetration of remote monitoring services for pets is expected to open new avenues for the market growth in the coming years.
The global animal aids market is segmented into product type, animal type, end user, and region. On the basis of product type, the market is divided into medicinal products, nutritional supplements, diagnostic products, surgical equipment, and wound care products. By animal type, it is classified into companion animals, livestock animal, and wildlife animal. Depending on end user, it is categorized into veterinary clinics & hospitals, animal shelters & rescue centers, farms & ranches, and pet owners. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product type, the medicinal product segment accounted for the largest share in 2023 in the animal aids market.
Depending on animal type, the companion animal segment was the major shareholder in 2023.
On the basis of end user, the veterinary clinics & hospitals segment dominated the market in 2023.
Region wise, North America was the key revenue contributor in 2023, and is expected to dominate the market in the coming years.

Competition Analysis

Competitive analysis and profiles of the major players in the global animal aids market include Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health, Merck Animal Health, Bayer Animal Health, CEVA Santé Animale S.A.S., Virbac, Vetoquinol, Dechra Pharmaceuticals Plc., and Phibro Animal Health Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Key Market Segments

By Product Type

Medicinal Products
Nutritional Supplements
Diagnostic Products
Surgical Equipment
Wound Care Products

By Animal Type

Companion Animals
Livestock Animal
Wildlife Animal.

By End User

Veterinary Clinics and Hospitals
Animal Shelters and Rescue Center
Farms and Ranches
Pet Owners

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Zoetis Inc.
Boehringer Ingelheim Animal Health
Elanco Animal Health
Merck Animal Health
Bayer Animal Health
CEVA Santé Animale S.A.S.
Virbac
Vetoquinol
Dechra Pharmaceuticals plc.
Phibro Animal Health Corporation.


CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ANIMAL AIDS MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Medicinal Products
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Nutritional Supplements
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Diagnostic Products
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Surgical Equipment
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Wound Care Products
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
CHAPTER 5: ANIMAL AIDS MARKET, BY ANIMAL TYPE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Animal Type
5.2. Companion Animals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Livestock Animal
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Wildlife Animal.
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: ANIMAL AIDS MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Veterinary Clinics And Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Animal Shelters And Rescue Center
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Farms And Ranches
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Pet Owners
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: ANIMAL AIDS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product Type
7.2.3. Market Size and Forecast, By Animal Type
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Animal Aids Market
7.2.6.1. Market Size and Forecast, By Product Type
7.2.6.2. Market Size and Forecast, By Animal Type
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Animal Aids Market
7.2.7.1. Market Size and Forecast, By Product Type
7.2.7.2. Market Size and Forecast, By Animal Type
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Animal Aids Market
7.2.8.1. Market Size and Forecast, By Product Type
7.2.8.2. Market Size and Forecast, By Animal Type
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product Type
7.3.3. Market Size and Forecast, By Animal Type
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Animal Aids Market
7.3.6.1. Market Size and Forecast, By Product Type
7.3.6.2. Market Size and Forecast, By Animal Type
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Animal Aids Market
7.3.7.1. Market Size and Forecast, By Product Type
7.3.7.2. Market Size and Forecast, By Animal Type
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Animal Aids Market
7.3.8.1. Market Size and Forecast, By Product Type
7.3.8.2. Market Size and Forecast, By Animal Type
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Animal Aids Market
7.3.9.1. Market Size and Forecast, By Product Type
7.3.9.2. Market Size and Forecast, By Animal Type
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Animal Aids Market
7.3.10.1. Market Size and Forecast, By Product Type
7.3.10.2. Market Size and Forecast, By Animal Type
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Animal Aids Market
7.3.11.1. Market Size and Forecast, By Product Type
7.3.11.2. Market Size and Forecast, By Animal Type
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product Type
7.4.3. Market Size and Forecast, By Animal Type
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Animal Aids Market
7.4.6.1. Market Size and Forecast, By Product Type
7.4.6.2. Market Size and Forecast, By Animal Type
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Animal Aids Market
7.4.7.1. Market Size and Forecast, By Product Type
7.4.7.2. Market Size and Forecast, By Animal Type
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Animal Aids Market
7.4.8.1. Market Size and Forecast, By Product Type
7.4.8.2. Market Size and Forecast, By Animal Type
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Animal Aids Market
7.4.9.1. Market Size and Forecast, By Product Type
7.4.9.2. Market Size and Forecast, By Animal Type
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Animal Aids Market
7.4.10.1. Market Size and Forecast, By Product Type
7.4.10.2. Market Size and Forecast, By Animal Type
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Animal Aids Market
7.4.11.1. Market Size and Forecast, By Product Type
7.4.11.2. Market Size and Forecast, By Animal Type
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product Type
7.5.3. Market Size and Forecast, By Animal Type
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Animal Aids Market
7.5.6.1. Market Size and Forecast, By Product Type
7.5.6.2. Market Size and Forecast, By Animal Type
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Animal Aids Market
7.5.7.1. Market Size and Forecast, By Product Type
7.5.7.2. Market Size and Forecast, By Animal Type
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Animal Aids Market
7.5.8.1. Market Size and Forecast, By Product Type
7.5.8.2. Market Size and Forecast, By Animal Type
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Animal Aids Market
7.5.9.1. Market Size and Forecast, By Product Type
7.5.9.2. Market Size and Forecast, By Animal Type
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Zoetis Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Boehringer Ingelheim Animal Health
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Elanco Animal Health
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Merck Animal Health
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Bayer Animal Health
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. CEVA Santé Animale S.A.S.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Virbac
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Vetoquinol
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Dechra Pharmaceuticals Plc.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Phibro Animal Health Corporation.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 2. ANIMAL AIDS MARKET FOR MEDICINAL PRODUCTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ANIMAL AIDS MARKET FOR NUTRITIONAL SUPPLEMENTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. ANIMAL AIDS MARKET FOR DIAGNOSTIC PRODUCTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. ANIMAL AIDS MARKET FOR SURGICAL EQUIPMENT, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. ANIMAL AIDS MARKET FOR WOUND CARE PRODUCTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 8. ANIMAL AIDS MARKET FOR COMPANION ANIMALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. ANIMAL AIDS MARKET FOR LIVESTOCK ANIMAL, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. ANIMAL AIDS MARKET FOR WILDLIFE ANIMAL., BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. GLOBAL ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 12. ANIMAL AIDS MARKET FOR VETERINARY CLINICS AND HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. ANIMAL AIDS MARKET FOR ANIMAL SHELTERS AND RESCUE CENTER, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. ANIMAL AIDS MARKET FOR FARMS AND RANCHES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 15. ANIMAL AIDS MARKET FOR PET OWNERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 16. ANIMAL AIDS MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 17. NORTH AMERICA ANIMAL AIDS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 18. NORTH AMERICA ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 19. NORTH AMERICA ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 20. NORTH AMERICA ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 21. U.S. ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 22. U.S. ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 23. U.S. ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 24. CANADA ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 25. CANADA ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 26. CANADA ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 27. MEXICO ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 28. MEXICO ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 29. MEXICO ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 30. EUROPE ANIMAL AIDS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 31. EUROPE ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 32. EUROPE ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 33. EUROPE ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 34. FRANCE ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 35. FRANCE ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 36. FRANCE ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. GERMANY ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 38. GERMANY ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 39. GERMANY ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 40. ITALY ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 41. ITALY ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 42. ITALY ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 43. SPAIN ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 44. SPAIN ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 45. SPAIN ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 46. UK ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 47. UK ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 48. UK ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. REST OF EUROPE ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 50. REST OF EUROPE ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 51. REST OF EUROPE ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 52. ASIA-PACIFIC ANIMAL AIDS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 53. ASIA-PACIFIC ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 54. ASIA-PACIFIC ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 55. ASIA-PACIFIC ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 56. CHINA ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 57. CHINA ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 58. CHINA ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 59. JAPAN ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 60. JAPAN ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 61. JAPAN ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 62. INDIA ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 63. INDIA ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 64. INDIA ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 65. SOUTH KOREA ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 66. SOUTH KOREA ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 67. SOUTH KOREA ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 68. AUSTRALIA ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 69. AUSTRALIA ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 70. AUSTRALIA ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 71. REST OF ASIA-PACIFIC ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 72. REST OF ASIA-PACIFIC ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 73. REST OF ASIA-PACIFIC ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 74. LAMEA ANIMAL AIDS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 75. LAMEA ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 76. LAMEA ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 77. LAMEA ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 78. BRAZIL ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 79. BRAZIL ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 80. BRAZIL ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 81. SOUTH AFRICA ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 82. SOUTH AFRICA ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 83. SOUTH AFRICA ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 84. SAUDI ARABIA ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 85. SAUDI ARABIA ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 86. SAUDI ARABIA ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 87. REST OF LAMEA ANIMAL AIDS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 88. REST OF LAMEA ANIMAL AIDS MARKET, BY ANIMAL TYPE, 2024 - 2033 ($BILLION)
TABLE 89. REST OF LAMEA ANIMAL AIDS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 90. ZOETIS INC.: KEY EXECUTIVES
TABLE 91. ZOETIS INC.: COMPANY SNAPSHOT
TABLE 92. ZOETIS INC.: OPERATING SEGMENTS
TABLE 93. ZOETIS INC.: PRODUCT PORTFOLIO
TABLE 94. ZOETIS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95. BOEHRINGER INGELHEIM ANIMAL HEALTH: KEY EXECUTIVES
TABLE 96. BOEHRINGER INGELHEIM ANIMAL HEALTH: COMPANY SNAPSHOT
TABLE 97. BOEHRINGER INGELHEIM ANIMAL HEALTH: OPERATING SEGMENTS
TABLE 98. BOEHRINGER INGELHEIM ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 99. BOEHRINGER INGELHEIM ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. ELANCO ANIMAL HEALTH: KEY EXECUTIVES
TABLE 101. ELANCO ANIMAL HEALTH: COMPANY SNAPSHOT
TABLE 102. ELANCO ANIMAL HEALTH: OPERATING SEGMENTS
TABLE 103. ELANCO ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 104. ELANCO ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. MERCK ANIMAL HEALTH: KEY EXECUTIVES
TABLE 106. MERCK ANIMAL HEALTH: COMPANY SNAPSHOT
TABLE 107. MERCK ANIMAL HEALTH: OPERATING SEGMENTS
TABLE 108. MERCK ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 109. MERCK ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110. BAYER ANIMAL HEALTH: KEY EXECUTIVES
TABLE 111. BAYER ANIMAL HEALTH: COMPANY SNAPSHOT
TABLE 112. BAYER ANIMAL HEALTH: OPERATING SEGMENTS
TABLE 113. BAYER ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 114. BAYER ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115. CEVA SANTé ANIMALE S.A.S.: KEY EXECUTIVES
TABLE 116. CEVA SANTé ANIMALE S.A.S.: COMPANY SNAPSHOT
TABLE 117. CEVA SANTé ANIMALE S.A.S.: OPERATING SEGMENTS
TABLE 118. CEVA SANTé ANIMALE S.A.S.: PRODUCT PORTFOLIO
TABLE 119. CEVA SANTé ANIMALE S.A.S.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120. VIRBAC: KEY EXECUTIVES
TABLE 121. VIRBAC: COMPANY SNAPSHOT
TABLE 122. VIRBAC: OPERATING SEGMENTS
TABLE 123. VIRBAC: PRODUCT PORTFOLIO
TABLE 124. VIRBAC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 125. VETOQUINOL: KEY EXECUTIVES
TABLE 126. VETOQUINOL: COMPANY SNAPSHOT
TABLE 127. VETOQUINOL: OPERATING SEGMENTS
TABLE 128. VETOQUINOL: PRODUCT PORTFOLIO
TABLE 129. VETOQUINOL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130. DECHRA PHARMACEUTICALS PLC.: KEY EXECUTIVES
TABLE 131. DECHRA PHARMACEUTICALS PLC.: COMPANY SNAPSHOT
TABLE 132. DECHRA PHARMACEUTICALS PLC.: OPERATING SEGMENTS
TABLE 133. DECHRA PHARMACEUTICALS PLC.: PRODUCT PORTFOLIO
TABLE 134. DECHRA PHARMACEUTICALS PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 135. PHIBRO ANIMAL HEALTH CORPORATION.: KEY EXECUTIVES
TABLE 136. PHIBRO ANIMAL HEALTH CORPORATION.: COMPANY SNAPSHOT
TABLE 137. PHIBRO ANIMAL HEALTH CORPORATION.: OPERATING SEGMENTS
TABLE 138. PHIBRO ANIMAL HEALTH CORPORATION.: PRODUCT PORTFOLIO
TABLE 139. PHIBRO ANIMAL HEALTH CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL ANIMAL AIDS MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ANIMAL AIDS MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ANIMAL AIDS MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALANIMAL AIDS MARKET
FIGURE 10. GLOBAL ANIMAL AIDS MARKET SEGMENTATION, BY PRODUCT TYPE
FIGURE 11. ANIMAL AIDS MARKET FOR MEDICINAL PRODUCTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ANIMAL AIDS MARKET FOR NUTRITIONAL SUPPLEMENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. ANIMAL AIDS MARKET FOR DIAGNOSTIC PRODUCTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. ANIMAL AIDS MARKET FOR SURGICAL EQUIPMENT, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. ANIMAL AIDS MARKET FOR WOUND CARE PRODUCTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL ANIMAL AIDS MARKET SEGMENTATION, BY ANIMAL TYPE
FIGURE 17. ANIMAL AIDS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. ANIMAL AIDS MARKET FOR LIVESTOCK ANIMAL, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. ANIMAL AIDS MARKET FOR WILDLIFE ANIMAL., BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. GLOBAL ANIMAL AIDS MARKET SEGMENTATION, BY END USER
FIGURE 21. ANIMAL AIDS MARKET FOR VETERINARY CLINICS AND HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. ANIMAL AIDS MARKET FOR ANIMAL SHELTERS AND RESCUE CENTER, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 23. ANIMAL AIDS MARKET FOR FARMS AND RANCHES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 24. ANIMAL AIDS MARKET FOR PET OWNERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 29. COMPETITIVE DASHBOARD
FIGURE 30. COMPETITIVE HEATMAP: ANIMAL AIDS MARKET
FIGURE 31. TOP PLAYER POSITIONING, 2023
FIGURE 32. ZOETIS INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 33. ZOETIS INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 34. ZOETIS INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 35. BOEHRINGER INGELHEIM ANIMAL HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 36. BOEHRINGER INGELHEIM ANIMAL HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 37. BOEHRINGER INGELHEIM ANIMAL HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 38. ELANCO ANIMAL HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 39. ELANCO ANIMAL HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 40. ELANCO ANIMAL HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 41. MERCK ANIMAL HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 42. MERCK ANIMAL HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 43. MERCK ANIMAL HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 44. BAYER ANIMAL HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 45. BAYER ANIMAL HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 46. BAYER ANIMAL HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 47. CEVA SANTé ANIMALE S.A.S.: NET SALES, 2021-2023 ($BILLION)
FIGURE 48. CEVA SANTé ANIMALE S.A.S.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 49. CEVA SANTé ANIMALE S.A.S.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 50. VIRBAC: NET SALES, 2021-2023 ($BILLION)
FIGURE 51. VIRBAC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 52. VIRBAC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 53. VETOQUINOL: NET SALES, 2021-2023 ($BILLION)
FIGURE 54. VETOQUINOL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 55. VETOQUINOL: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 56. DECHRA PHARMACEUTICALS PLC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 57. DECHRA PHARMACEUTICALS PLC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 58. DECHRA PHARMACEUTICALS PLC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 59. PHIBRO ANIMAL HEALTH CORPORATION.: NET SALES, 2021-2023 ($BILLION)
FIGURE 60. PHIBRO ANIMAL HEALTH CORPORATION.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 61. PHIBRO ANIMAL HEALTH CORPORATION.: REVENUE SHARE, BY REGION, 2023 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings